Cellular tumor vaccines administered after T cell-depleted allogeneic bone marrow transplantation induce effective anti-tumor immune responses

REFERENCES

• Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 1995;86:2041–2050.
   Google Scholar
• Sullivan KM, Storb R, Buckner CD, Fefer A, Fisher L, Weiden PL, Witherspoon RP, Appelbaum FR, Banaji M, Hansen J et al. Graft-versus-host disease as adoptive im-munotherapy in patients with advanced hematologic neoplasms. N Engl J Med 1989;320:828–834.
   Google Scholar
• Marmont AM, Horowitz MM, Gale RP, Sobocinski K, Ash RC, van Bekkum DW, Champlin RE, Dicke KA, Goldman JM, Good RA et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991;78:2120–2130.
   Google Scholar
• Blaise D, Olive D, Michallet M, Marit G, Leblond V, Maraninchi D. Impairment of leukaemia-free survival by addition of interleukin-2-receptor antibody to standard graft-versus-host prophylaxis. Lancet 1995;345:1144–1146.
   Google Scholar
• van der Straaten HM, Fijnheer R, Dekker AW, Nieuwenhuis HK, Verdonck LF. Relationship between graft-versus-host disease and graft-versus-leukaemia in partial T cell-depleted bone marrow transplantation. Br J Haematol 2001;114:31–35.
   Google Scholar
• Lee CK, deMagalhaes-Silverman M, Hohl RJ, Hayashi M, Buatti J, Wen BC, Schlueter A, Strauss RG, Gingrich RD. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3 + T-cell-depleted graft. Bone Marrow Transplant 2003;31: 121–128.
   Google Scholar
• Mutis T, Verdijk R, Schrama E, Esendam B, Brand A, Goulmy E. Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility anti-gens. Blood 1999;93:2336–2341.
   Google Scholar
• Greten TF, Jaffee EM. Cancer vaccines. J Chin Oncol 1999;17:1047–1060.
   Google Scholar
• Dickinson AM, Wang XN, Sviland L, Vyth-Dreese FA, Jackson GH, Schumacher TN, Haanen JB, Mutis T, Goulmy E. In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens. Nat Med 2002;8:410–414.
   Google Scholar
• Anderson LD, Savary CA, Mullen CA. Immunization of allogeneic bone marrow transplant recipients with tumor cell vaccines enhances graft-versus-tumor activity without exacer-bating graft-versus-host disease. Blood 2000;95:2426–2433.
   Google Scholar
• Zoller M. Tumor vaccination after allogeneic bone marrow cell reconstitution of the nonmyeloablatively conditioned tumor-bearing murine host. J Immunol 2003;171:6941–6953.
   Google Scholar
• Korngold R, Sprent J. Variable capacity of L3T4 + T cells to cause lethal graft-versus-host disease across minor histocom-patibility barriers in mice. J Exp Med 1987;165:1552–1564.
   Google Scholar
• Green MC, Witham BA. Handbook on genetically standar-dized Jax mice. 4th ed. Bar Harbor, Maine: Jackson Laboratory; 1991.
   Google Scholar
• Kernan NA. T-cell depletion for the prevention of graft-versus-host disease. In: Thomas ED, Blume KG, Forman SJ, editors. Hematopoietic cell transplantation. Malden, Massa-chusetts: Blackwell Science; 1999. p 186–196.
   Google Scholar
• Restifo NP, Esquivel F, Asher AL, Stotter H, Barth RJ, Bennick JR, Mule JJ, Yewdell JW, Rosenberg SA. Defective presentation of endogenous antigens by a murine sarcoma: implications for the failure of an anti-tumor immune response. J Immunol 1991;147:1453–1459.
   Google Scholar
• Wei ML, Cresswell P. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived pep-tides. Nature 1992;356:443–446.
   Google Scholar
• Sanburn N, Cornetta K. Rapid titer determination using quantitative real-time PCR Gene Ther 1999;6:1340–1345.
   Google Scholar
• Eden PA, Christianson GJ, Fontaine P, Wettstein PJ, Perreault C, Roopenian DC. Biochemical and immunogenetic analysis of an immunodominant peptide (B6dom 1) encoded by the classical H7 minor histocompatibility locus. J Immunol 1999;162:4502–4510.
   Google Scholar
• Perreault C, Jurras J, Roy DC, Filep JG, Brochu S. Identification of an immunodominant mouse minor histo-compatibility antigen (MiHA). T cell response to a single dominant MiHA causes graft-versus-host disease. J Chin Invest 1996;98:622–628.
   Google Scholar
• Anderson LD, Mori S, Mann S, Savary CA, Mullen CA. Pretransplant tumor antigen-specific immunization of allo-geneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease. Cancer Res 2000;60:5797–5802.
   Google Scholar
• Anderson LJ, Petropoulos D, Everse LA, Mullen CA. Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccine. Cancer Res 1999;59:1525–1530.
   Google Scholar
• Godthelp BC, van Tol MJ, Vossen JM, van Den Elsen PJ. T-cell immune reconstitution in pediatric leukemia patients after allogeneic bone marrow transplantation with T-cell-depleted or unmanipulated grafts: evaluation of overall and antigen-specific T-cell repertoires. Blood 1999;94:4358–4369.
   Google Scholar
• Lamb LS Jr, Henslee-Downey PJ, Parrish RS, Godder K, Thompson J, Lee C, Gee AP. Increased frequency of TCR gamma delta + T cells in disease-free survivors following T cell-depleted, partially mismatched, related donor bone marrow transplantation for leukemia. J Hematother 1996;5:503–509.
   Google Scholar
• Lamb LS Jr, Gee AP, Henslee-Downey PJ, Geier SS, Hazlett L, Pati AR, Godder K, Abhyankar SA, Turner MW, Lee C et al. Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell-depleted bone marrow transplantation from partially mismatched related donors. Bone Marrow Transplant 1998;21:461–471.
   Google Scholar
• Teshima T, Mach N, Hill GR, Pan L, Gillessen S, Dranoff G, Ferrera JL. Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation. Cancer Res 2001;61:162–171.
   Google Scholar
• Hakim FT, Cepeda R, Kaimei S, Mackall CL, McAtee N, Zujewski J, Cowan K, Gress RE. Constraints on CD4 recovery postchemotherapy in adults: thymic insufficiency and apopto-tic decline of expanded peripheral CD4 cells. Blood 1997;90:3789–3798.
   Google Scholar
• Mackall CL, Gress RE. Thymic aging and T-cell regeneration. Immunol Rev 1997;160:91–102.
   Google Scholar